close
read more
Our company
Governance
Global presence
Key figures
Story
Vocation, vision and values
Culture
Financial Results
Servier Institute
Our healthcare offering
Servier medicines
Generic medicines
e-Health solutions
Our areas of expertise
Research & Development
Therapeutic areas
Development portfolio
Clinical trials
Regulatory affairs
Pharmacovigilance
Servier Paris-Saclay R&D Institute
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Third-Party Sponsor studies
Business development & licensing
Our commitments
Patient
Ethics
Compliance policy
CSR approach
Fight against counterfeiting
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate publishing
Medical publishing
FR
MEDIATOR INFORMATION
NEWS
ROOM
News
Press release
Insight
Corporate publishing
Medical publishing
Servier obtains Top Employer Europe 2021 certification
25 / 01 / 2021
Press release
Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases
21 / 01 / 2021
Press release
Financial Year 2019/2020 – Financial results and R&D strategy and pipeline
19 / 01 / 2021
Press release
Servier appoints Pascal Lemaire as Executive Vice President Finance
07 / 01 / 2021
Press release
Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases
06 / 01 / 2021
Press release
Servier to Acquire Agios Pharmaceuticals’ Oncology Business
21 / 12 / 2020
Press release
Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer
21 / 12 / 2020
Press release
The Servier Group opens a worldwide Artificial Intelligence Hub in Montreal, in partnership with Centech
14 / 12 / 2020
Press release
The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
14 / 12 / 2020
Press release
Servier launches its first oncology treatment in the solid tumor field in Brazil
08 / 12 / 2020
Press release
Skolkovo and Servier support Russian startups in the field of oncology and autoimmune diseases
19 / 11 / 2020
Press release
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
15 / 10 / 2020
Press release